Alkermes (Nasdaq: ALKS) is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
Recent Mentions on Fool.com
- Why I Think Alkermes Could Be a Top Performing Stock Ahead of 2016
- Midyear Report Card: Grading My Biotech Predictions for 2015
- A New Drug Could Halt Weight Gain in Patients Taking These Antipsychotics
- This Could Be Game-Changing News in the Battle Against Multiple Sclerosis
- 5 Predictions for Biotechnology Stocks in 2015